Key Adverse Events Following Childhood Cancer
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: childhood cancer
Age: Between 0 - 21 Years
Gender: Male or Female
Diagnosis of primary cancer at age 21 or younger
In active follow-up by a Children's Oncology Group (COG) institution
Development of one of the following key adverse events after initiation of prior cancer therapy:Cardiac dysfunction, Myocardial infarction, Ischemic stroke, Avascular necrosis, Subsequent malignant neoplasm
Prior allogeneic (non-autologous) hematopoietic cell transplant
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required